Businesses invest a large amount of time and money in developing and marketing a product or service, and understandably want the public to recognise it as being theirs and theirs alone.
Trade marks allow a person or business to indicate the origin of their goods and/or services, whilst helping to distinguish their business from those of third parties.
FACT – A trade mark can take a number of forms, including words, logos or more unconventional indicators of trade origin such as smells, sounds or even multimedia marks.
Here are our Top Trade Mark Tips highlighting the benefits of protecting your IP!
It secures for the owner exclusive rights in the trade mark in relation to the goods/services for which it is registered.
A trade mark registration entitles the owner to use the ® symbol. This puts third parties on notice that using the mark may constitute an infringement.
It provides the owner with rights and remedies to stop competitors infringing the trade mark, i.e. utilising an identical or similar mark within the same sector. The remedies available include a permanent injunction to stop the infringing use, destruction of the infringing goods and packaging, damages or an account of profits, and payment of legal fees.
It acts as a deterrent to third parties wishing to adopt identical/similar trade marks.
It provides authorities with the required ammunition to bring action against counterfeiters.
It adds value to your business. The wealth of some of the world’s largest and most successful companies lies in their trade marks.
Once registered, the trade mark becomes intangible property and can be licensed, franchised or assigned; thereby potentially generating revenue.
Our trade mark team has a wealth of experience across a number of sectors. The team will be able to help you with everything from registering your trade mark, through to anti-counterfeiting, watching services and maximising the commercial output of your trade mark.
Click for more information about our trade marks services and to meet our trade mark team.
On the 13th-14th June 2018, agri-food researchers across the N8 universities: Durham, Lancaster, Leeds, Liverpool, Manchester, Newcastle, Sheffield and York join leaders in the global food and supply chain ecosystem in Liverpool to connect, collaborate and re-imagine the market places of tomorrow.
The aim?
To inspire, educate and foster the future of a truly sustainable food system.
Anna Gregson, Partner at Mathys and Squire, will be speaking alongside the following to name but a few:
Click for further information about the N8 event People, Health & Food Systems: Challenges & Solutions for 2030.
To find out more about our Agri-Tech and Food sectors explore our site or contact Anna Gregson via [email protected]
The 16th May 2018 saw the new UK Life Sciences Council meet for the first time. The UK Life Sciences Council is a partnership between government and industry, which follows on from the Life Sciences Sector Deal, involving commitments and investments into the UK by 25 global organisations from across the life sciences sector.
The main objectives of the partnership are:
Co-chaired by Business Secretary, Greg Clark, and Health and Social Care Secretary, Jeremy Hunt, the meeting was attended by a range of life sciences industry experts, representing medical devices, biotech and pharmaceuticals.
Discussions unsurprisingly included Brexit, particularly the importance of the supply of medicines, regulatory alignment and the needs of patients. The Government emphasised its commitment to achieving a good outcome for the life sciences sector during the Brexit negotiations, and its desire to continue the UK’s history of innovation in this area. The UK continues to have extremely buoyant health and life sciences sectors, worth over £70 billion to the UK economy and providing jobs for almost 241,000 people across the country.
If you have any questions about life sciences and strategies ahead of Brexit, please contact Managing Associate, Bethanny Gibbs on [email protected].
Bethany has a Master’s degree in Natural Sciences, specialising in Neuroscience, from the University of Cambridge, and is a qualified European Patent Attorney and UK qualified Chartered Patent Attorney. Working alongside Mathys & Squire Partners Monika Rai and David Miller, Bethany is involved in European prosecution, opposition and appeal work in the fields of pharmacology and biotechnology, as well as the provision of freedom-to-operate opinions and associated strategic advice.
Tax, business structuring, patents and intellectual property protection can be a minefield, whether you are setting up a new tech venture or growing and expanding your existing business.
Want to learn more about getting it right from the outset?
Join us for an interactive panel discussion and networking reception on Wednesday 13th June with professional experts and like-minded members of the tech community.
The panel comprises those experienced in working with UK and international tech businesses with regards to tax, business structuring, IP protection and commercialisation.
Tech entrepreneurs Varun Shoor – Founder of Kayako and Norman Shaw – Founder of ExactTrak will also be joining and providing their insights and lessons learned from their start-up journey!
When: Wednesday 13 June 2018
Where: Mathys & Squire, The Shard, 32 London Bridge Street, SE1 9SG
Time: 18:00 registration / 18:30 panel / 19:30 drinks & networking
Remember to bring PHOTO ID.
The European Commission has recently published a notice on the consequences of Brexit on supplementary protection certificates (SPCs) for medicinal and plant protection products.
According to the law on SPCs, the date of the first authorisation to place a medicinal or plant protection product on the market in the European Economic Area is used to calculate the duration of supplementary protection that is available, as well as the deadline for filing an application for an SPC.
The notice confirms, perhaps unsurprisingly, that as of the date of withdrawal of the UK from the EU and subject to any transitional provisions, an authorisation to place a medicinal or plant protection product on the market granted by a UK authority will not be considered a first authorisation for SPC purposes in the EU. Any UK authorisations granted before the withdrawal date will, however, continue to be accepted.
The notice also confirms that, as of the withdrawal date, the EU SPC legislation will no longer apply to the UK. The EU and UK are in the process of agreeing how an application for an SPC in the UK that was submitted before, but is pending at, the withdrawal date should be treated. The EU’s position is that any such applications should, when granted, provide protection comparable to that provided for by EU law.
The UK is currently set to leave the EU on 30 March 2019, although the withdrawal date may be delayed on agreement between the EU and UK. Furthermore, transitional provisions will, quite likely, mean that EU law will continue to apply in the UK beyond the withdrawal date. Whilst the UK has yet to confirm the arrangements for any future domestic SPC regime, it seems likely that it will still be possible to apply for and obtain SPCs in the UK after Brexit.
For queries or advice about SPCs, please contact Mathys & Squire Partner, James Wilding via [email protected]
James’ practice is focused on EPO prosecution and opposition work in the life sciences sector. He also has extensive experience with SPCs and has prosecuted SPC applications covering a number of blockbuster drugs. James has a master’s degree in biochemistry and a doctorate on the biochemistry of heart disease, both from Oxford University.
The Mathys & Squire Litigation team are currently working on an exciting research project to look at organisations’ experience and approach to IP litigation.
We are looking for organisations/individuals that have experience of IP litigation and would be interested in taking part in a short telephone survey.
If you are interested in being involved in this exciting project or have any questions, please email [email protected].
Join Mathys & Squire at London’s Tech Week start-up event – Project Kairos, a dedicated start-up programme which is aimed at connecting startups with industry and investment.
From 12th-14th June our intellectual property attorneys will be at the Excel Centre and ready to answer any questions about intellectual property protection, strategy and key insights to turn start-ups to success stories.
Managing Associate, Andy White, will also be taking part in a panel discussion on 14th June at 12:15. If you want to know more about “Getting your operational ship in shape” we will see you there!
For the full agenda and registration information click here.
Andrew is a European Patent Attorney, a chartered UK Patent Attorney and holds both a Master’s degree and a PhD in physics from the University of Bristol. During the course of his PhD, sponsored by GSK, Andrew gained valuable insights into the world of commercial R&D and published a number of papers, book chapters and spoke at numerous international conferences – a skill which he now uses to give presentations on IP to both students and clients.
Partners Anna Gregson, Mike Stott and Dani Kramer from intellectual property firm, Mathys and Squire, recently attended Agritech Israel 2018, Tel Aviv’s 20th International Agricultural Technology Exhibition on agricultural technologies, innovations and food processing. They outline their views below on the event itself and the growing importance of the agri-tech industry.
With the theme “agriculture in arid and semi-arid regions”, the conference was dedicated to the challenges and solutions facing these global regions with attendees sharing ideas on the advanced techniques aimed at increasing the productivity of agricultural industries.
Dani Kramer noted “it was fascinating meeting individuals from such a diverse variety of companies across the agri-tech sector and learning about how their innovative technologies have helped them to grow their businesses.”
Why focus on Agritech?
Anna Gregson explains “primary food production is the biggest industry in the world and ensuring the stability and integrity of national and international food supply chains is crucial. With ever increasing challenges to expand food production in a sustainable way whilst reducing environmental impact, new technology is key to addressing these challenges.”
Why Israel?
In view of its arid geography, Israel’s agriculture sector has by necessity been forced to the at the forefront of agri-tech innovation, particularly in the areas of irrigation, water reuse and the development of plants and agricultural products to maximise production in extreme weather conditions. Mike Stott added that Israel is also a hotbed of innovation and start-ups more generally. With a population of only 7 million, Israel attracts approximately $2 billion in venture capital funding each year – to give some perspective, this is about as much funding as both Germany and France attract combined. Plus it is second only to Silicon Valley in producing start-ups.
What were the key trends from the conference?
Israeli agri-tech innovation has allowed crop growers to cultivate barren regions by using them as greenhouses. Israeli innovators have been at the forefront of drip irrigation, which uses slow and balanced water supply to achieve exceptional growth and also water recycling and reuse.
Why is Mathys and Squire suited to work with Israeli companies?
Our combination of technical expertise, local knowledge and commercial focus enables us to deliver results for our clients whilst understanding the culture of Israeli businesses and the unique challenges facing the Israeli market. As a result, we have developed strong relationships with associate law firms in Israel, helping them provide expert advice to Israeli businesses seeking to establish a strong foothold in the European market.
If you have any questions about Israeli innovation or the agri-tech sector, please get in touch via one of the email addresses below.
Dani heads up our specialist Israel practice after spending years working with Israeli clients and attorney firms based in Israel. He works for a number of large corporations, drafting and prosecuting patent applications, and managing their international patent portfolios.
Mike has a first class master’s degree in chemistry from the University of York and has worked in the patent profession since 2008. He has been involved in the drafting and prosecution of patent applications in the UK, Europe, and many overseas jurisdictions, including the US.
Anna has a first class MA honours degree in natural sciences, specialising in pathology from the University of Cambridge and a PhD in biochemistry from the University of Manchester. Anna has a breadth of experience in the fields of biotechnology and life sciences.
We would be delighted if you would join us at The Varsity Hotel and Spa on Thursday 7th June.
Join the patent and trade mark teams for drinks and canapés on the roof terrace and enjoy panoramic views of Cambridge.
When: Thursday 7th June 2018
Time: 18.00 – 21.00
Where: Thompson’s Lane, CAMBRIDGE CB5 8AQ
Please click here to RSVP by 1st June to confirm your attendance and let us know if you have any dietary requirements. We look forward to seeing you!
Many will have noticed the recent decision by EU member states to endorse the European Commission’s proposal to completely ban all outdoor use of certain, widely-used neo-nicotinoid pesticides, which have been reported to have a detrimental effect on honeybee and wild bee populations. This has followed a decision in 2013 to only ban the use of such pesticides on flowering crops; those which are most likely to attract bees.
Whilst the UK was one of the member states to oppose the partial ban initially, Michael Gove, the Government’s Environment Secretary, has indicated that in the light of further evidence highlighted in a report by the UK Expert Committee on Pesticides (ECP), extending the ban as proposed by the Commission is something that the Environment Secretary now considers to be justified.
Whilst many will see the ban as a victory for conserving bee populations, which have historically served certain sectors of the food industry well with their pollination prowess, as well as for reducing the incidence of pesticide contamination in food products, others see the measures as overly cautious and serving to rewind years of development of the farmer’s armoury against pests which can blight crop production. This comes at a time when concerns over global food shortages are steadily growing as current projected food production trends fall well short of the projected demand of a global population expected to reach 9 billion by 2050.
Agri-Science was identified in 2014 as part of the UK Intellectual Property Office’s (IPO) “Eight Great Technologies” report as a robust and growing area for innovation in the UK.
It seems that now more than ever the gauntlet has been thrown down for Agri-Tech innovation to respond to the further challenges to maximising crop production.
Nevertheless, we have already had glimpses of the new technologies which might provide the answer, including the use of drones and robotics, farm management software packages, vertical farming, aquaponic farms for urban environments, gene-editing and biological pesticides, to name but a few.
Thus, although the decision to reign in the use of certain pesticides might make crop protection that bit more difficult in the short term, innovation in this area is a promising sign that there will be other new tools for the farmer to rely on to maximise crop protection sustainably in the future.
Mathys & Squire’s Agri-Tech team are working with a range of businesses at the cutting edge of farming and food production.
If you want to know more about this topic or any other Agri-Tech related area, please contact Mathys & Squire partner, Mike Stott on [email protected]
Mike has a first class master’s degree in chemistry from the University of York, and was awarded the university’s ‘ICI Prize’ for his performance in the final examinations. Mike has worked in the patent profession since 2008 and prior to that worked in the pharmaceutical industry. He has been involved in the drafting and prosecution of patent applications in the UK, Europe, and many overseas jurisdictions, including the US.
